Basics Relay Therapeutics, Inc. IPO Date: July 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $710.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 3.37% Avg Daily Range (30 D): $0.10 | 2.74% Avg Daily Range (90 D): $0.10 | 3.00% Institutional Daily Volume Avg Daily Volume: .95M Avg Daily Volume (30 D): 1.82M Avg Daily Volume (90 D): 1.68M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 167 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 2,366 Avg Inst. Trade: $2.25M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.84M Avg Closing Trade (30 D): $.79M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 194.4K     News Sep 3, 2025 @ 11:00 AM Kymera Therapeutics Appoints Brian Adams as Chief ... Source: Brian Adams May 27, 2025 @ 1:45 PM Healthcare's Quiet AI Boom Is Creating a New Class... Source: Prnewswire Dec 11, 2024 @ 11:00 AM Relay Therapeutics Announces Updated Interim Data ... Source: N/A Sep 11, 2024 @ 10:46 PM Why Relay Therapeutics Plummeted by Nearly 14% Tod... Source: Eric Volkman Sep 11, 2024 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.41 $-.46 $-.42 Diluted EPS $-.41 $-.46 $-.42 Revenue $ .68M $ 7.68M $ M Gross Profit $ $ $ Net Income / Loss $ -70.38M $ -77.07M $ -76M Operating Income / Loss $ -76.85M $ -84.87M $ -84.98M Cost of Revenue $ $ $ Net Cash Flow $ -10.21M $ M $ -28.07M PE Ratio